Fjarde Ap-fonden’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.79M Buy
30,015
+3,100
+12% +$1.01M 0.09% 214
2025
Q1
$7.27M Sell
26,915
-2,200
-8% -$594K 0.09% 217
2024
Q4
$6.85M Buy
29,115
+1,300
+5% +$306K 0.07% 266
2024
Q3
$7.65M Buy
+27,815
New +$7.65M 0.08% 250
2024
Q1
$4.1M Sell
27,415
-500
-2% -$74.7K 0.05% 394
2023
Q4
$5.34M Sell
27,915
-500
-2% -$95.7K 0.07% 307
2023
Q3
$5.03M Sell
28,415
-100
-0.4% -$17.7K 0.07% 309
2023
Q2
$5.42M Sell
28,515
-1,400
-5% -$266K 0.07% 307
2023
Q1
$5.99M Buy
29,915
+1,000
+3% +$200K 0.08% 269
2022
Q4
$6.87M Sell
28,915
-1,800
-6% -$428K 0.1% 231
2022
Q3
$4.48M Hold
30,715
0.06% 357
2022
Q2
$4.48M Sell
30,715
-5,900
-16% -$861K 0.06% 357
2022
Q1
$5.98M Sell
36,615
-3,300
-8% -$539K 0.06% 346
2021
Q4
$6.77M Sell
39,915
-969
-2% -$164K 0.06% 330
2021
Q3
$7.72M Sell
40,884
-800
-2% -$151K 0.07% 281
2021
Q2
$7.07M Buy
41,684
+1,000
+2% +$170K 0.06% 312
2021
Q1
$5.74M Buy
40,684
+1,600
+4% +$226K 0.05% 366
2020
Q4
$5.08M Sell
39,084
-2,300
-6% -$299K 0.05% 373
2020
Q3
$6.03M Buy
41,384
+2,500
+6% +$364K 0.07% 284
2020
Q2
$5.76M Sell
38,884
-1,300
-3% -$193K 0.07% 277
2020
Q1
$4.37M Buy
40,184
+3,300
+9% +$359K 0.07% 274
2019
Q4
$4.25M Buy
36,884
+5,900
+19% +$680K 0.05% 397
2019
Q3
$2.49M Buy
30,984
+7,300
+31% +$587K 0.03% 492
2019
Q2
$1.72M Sell
23,684
-5,100
-18% -$370K 0.02% 560
2019
Q1
$2.69M Buy
28,784
+3,537
+14% +$331K 0.03% 490
2018
Q4
$1.84M Sell
25,247
-3,400
-12% -$248K 0.03% 496
2018
Q3
$2.51M Sell
28,647
-1,025
-3% -$89.7K 0.04% 522
2018
Q2
$2.92M Buy
29,672
+1,487
+5% +$146K 0.04% 487
2018
Q1
$3.36M Sell
28,185
-1,100
-4% -$131K 0.05% 417
2017
Q4
$3.72M Buy
+29,285
New +$3.72M 0.06% 387
2016
Q4
Sell
-23,211
Closed -$1.57M 627
2016
Q3
$1.57M Hold
23,211
0.03% 546
2016
Q2
$1.29M Sell
23,211
-262
-1% -$14.5K 0.03% 572
2016
Q1
$1.47M Buy
23,473
+1,892
+9% +$119K 0.03% 556
2015
Q4
$2.03M Buy
21,581
+544
+3% +$51.2K 0.05% 433
2015
Q3
$1.69M Hold
21,037
0.05% 483
2015
Q2
$2.52M Buy
+21,037
New +$2.52M 0.06% 377